BiotechTube
Home/Anokion/Deborah Geraghty
DG

Deborah Geraghty

Chief Executive Officer

Anokion

Therapeutic Areas

Autoimmune DiseasesCeliac DiseaseMultiple Sclerosis

Anokion Pipeline

DrugIndicationPhase
ANK-700Celiac DiseasePhase 1b/2
ANK-800Multiple SclerosisPhase 1

Leadership Team at Anokion

JH
John H. B. Johnson
Chief Scientific Officer
MB
Matthew B. Frankel
Chief Medical Officer
View full Anokion profile